Volume | 239,004 |
|
|||||
News | - | ||||||
Day High | 8.7573 | Low High |
|||||
Day Low | 8.15 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
CareDx Inc | CDNA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
8.15 | 8.15 | 8.7573 | 8.17 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
5,629 | 239,004 | $ 8.46 | $ 2,022,946 | - | 4.80 - 12.93 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:05:25 | 219 | $ 8.365 | USD |
CareDx Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
439.08M | 51.78M | - | 280.32M | -190.28M | -3.68 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
CareDx News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDNA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.08 | 8.7573 | 7.84 | 8.19 | 829,288 | 0.285 | 3.53% |
1 Month | 9.96 | 11.10 | 7.84 | 9.14 | 629,257 | -1.60 | -16.01% |
3 Months | 9.79 | 12.8337 | 7.83 | 9.73 | 809,686 | -1.43 | -14.56% |
6 Months | 5.21 | 12.93 | 4.80 | 9.36 | 1,058,018 | 3.16 | 60.56% |
1 Year | 8.70 | 12.93 | 4.80 | 9.01 | 942,306 | -0.335 | -3.85% |
3 Years | 75.73 | 96.88 | 4.80 | 23.52 | 898,199 | -67.37 | -88.95% |
5 Years | 25.72 | 99.83 | 4.80 | 28.84 | 826,994 | -17.36 | -67.48% |
CareDx Description
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden. |